| 25 May 2026 |
Oxytocin Acetate |
5.0 |
5mg |
5.8mg |
+16.3% |
96.77% |
Lab F |
| 24 May 2026 |
GHRP-6 Acetate |
5.0 |
30mg |
27.5mg |
-8.2% |
95.21% |
Lab A |
| 24 May 2026 |
L-Carnitine 500mg |
4.0 |
300mg/ml |
330.4mg/ml |
+10.1% |
97.11% |
Lab B |
| 24 May 2026 |
Minoxidil Oral |
4.0 |
50mg |
53.2mg |
+6.4% |
99.97% |
Lab E |
| 24 May 2026 |
Halotestin (Fluoxymesterone) |
4.0 |
20mg |
20.1mg |
+0.7% |
96.92% |
Lab G |
| 24 May 2026 |
SR9009 |
4.0 |
10mg |
10.6mg |
+6.4% |
96.32% |
Lab C |
| 24 May 2026 |
Hyaluronic acid |
4.0 |
20mg |
17.2mg |
-13.9% |
99.97% |
Lab F |
| 24 May 2026 |
Methylene Blue |
6.1 |
50mg |
48.9mg |
-2.3% |
95.67% |
Lab C |
| 24 May 2026 |
Minoxidil Oral |
4.1 |
20mg |
22.6mg |
+12.8% |
98.30% |
Lab C |
| 24 May 2026 |
SR9009 |
4.0 |
25mg |
26.3mg |
+5.4% |
97.62% |
Lab E |
| 24 May 2026 |
ACE-031 |
4.0 |
20mg |
19.5mg |
-2.4% |
98.59% |
Lab A |
| 24 May 2026 |
Tamoxifen (Nolvadex) |
4.3 |
50mg |
58.5mg |
+17.1% |
99.24% |
Lab E |
| 24 May 2026 |
BPC157 5mg + TB500 5mg Blend |
4.3 |
30mg |
30.7mg |
+2.5% |
96.05% |
Lab D |
| 24 May 2026 |
NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend |
4.0 |
10mg |
11.6mg |
+15.6% |
99.80% |
Lab B |
| 23 May 2026 |
Prostamax |
4.0 |
15mg |
17.4mg |
+16.0% |
96.87% |
Lab E |
| 23 May 2026 |
NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend |
4.0 |
2mg |
2.3mg |
+17.3% |
96.45% |
Lab D |
| 21 May 2026 |
BPC157 5mg + TB500 5mg Blend |
4.0 |
5mg |
5.3mg |
+6.2% |
99.60% |
Lab C |
| 21 May 2026 |
Tamoxifen (Nolvadex) |
5.4 |
100mg |
107.7mg |
+7.7% |
99.82% |
Lab A |
| 20 May 2026 |
DHB (1-Test Cyp) |
4.3 |
300mg/ml |
282.9mg/ml |
-5.7% |
95.21% |
Lab B |
| 20 May 2026 |
PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 |
7.6 |
100g |
89.9g |
-10.1% |
97.33% |
Lab D |
| 20 May 2026 |
Selank 10mg + Semax 10mg Blend |
4.7 |
50mg |
52.9mg |
+5.8% |
98.15% |
Lab B |
| 19 May 2026 |
AHK-CU |
4.0 |
50mg |
42.9mg |
-14.1% |
98.34% |
Lab A |
| 17 May 2026 |
Dapoxetine |
4.0 |
20mg |
21.3mg |
+6.3% |
98.60% |
Lab G |
| 17 May 2026 |
DHB (1-Test Cyp) Oral |
4.0 |
25mg |
23.6mg |
-5.7% |
97.73% |
Lab A |
| 17 May 2026 |
HGH 191AA (Somatropin) |
4.0 |
30mg |
34.9mg |
+16.3% |
96.12% |
Lab A |
| 29 Jan 2026 |
Boldenone Cypionate |
4.0 |
100mg/ml |
96.0mg/ml |
-4.0% |
95.32% |
Lab B |
| 29 Jan 2026 |
GHRP-6 Acetate |
6.5 |
5mg |
4.9mg |
-1.7% |
96.55% |
Lab G |
| 26 Jan 2026 |
4-AP (4-anilino-piperidine / N-phenyl-4-piperidinamine) CAS 23056-29-3 |
4.0 |
5g |
5.8g |
+16.2% |
98.11% |
Lab A |
| 26 Jan 2026 |
Tren Hex |
4.9 |
100mg/ml |
123.3mg/ml |
+23.3% |
95.97% |
Lab B |
| 19 Jan 2026 |
Alprostadil |
4.0 |
5mg |
6.0mg |
+19.2% |
97.09% |
Lab C |
| 9 Jan 2026 |
NandroMix 300 |
4.0 |
250mg/ml |
312.1mg/ml |
+24.8% |
97.53% |
Lab D |
| 9 Jan 2026 |
Oxytocin Acetate |
4.0 |
20mg |
18.2mg |
-8.8% |
97.04% |
Lab B |
| 7 Jan 2026 |
AICAR |
5.1 |
5mg |
5.5mg |
+10.5% |
98.64% |
Lab E |
| 6 Jan 2026 |
DHB (1-Test Cyp) |
4.8 |
100mg/ml |
109.7mg/ml |
+9.7% |
99.23% |
Lab A |
| 6 Jan 2026 |
RAD-140 (Testolone) Raw |
4.0 |
5g |
4.6g |
-8.3% |
98.94% |
Lab D |
| 6 Jan 2026 |
Semaglutide Raw |
4.0 |
100g |
98.4g |
-1.6% |
95.29% |
Lab C |
| 29 Dec 2025 |
Dapoxetine |
4.0 |
100mg |
124.1mg |
+24.1% |
99.90% |
Lab A |
| 29 Dec 2025 |
P-2-P (phenyl-2-propanone / BMK) CAS 103-79-7 |
4.0 |
500g |
621.5g |
+24.3% |
98.41% |
Lab D |
| 29 Dec 2025 |
Primobolan Oral (Methenolone Acetate) |
4.7 |
50mg |
59.4mg |
+18.8% |
96.13% |
Lab A |
| 12 Dec 2025 |
Cartalax |
4.0 |
20mg |
21.4mg |
+7.2% |
99.61% |
Lab A |
| 5 Dec 2025 |
DHB (1-Test Cyp) Oral |
5.0 |
50mg |
51.5mg |
+3.0% |
95.22% |
Lab B |
| 5 Dec 2025 |
Methylene Blue |
4.5 |
50mg |
43.6mg |
-12.8% |
97.15% |
Lab A |
| 5 Dec 2025 |
Selank 10mg + Semax 10mg Blend |
4.0 |
50mg |
43.0mg |
-13.9% |
96.41% |
Lab E |
| 23 Nov 2025 |
4-AP (4-anilino-piperidine / N-phenyl-4-piperidinamine) CAS 23056-29-3 |
4.0 |
500g |
482.7g |
-3.5% |
97.02% |
Lab G |
| 23 Nov 2025 |
Retatrutide 30mg Pen Kit |
4.4 |
20mg |
21.5mg |
+7.7% |
96.76% |
Lab C |
| 17 Nov 2025 |
Alprostadil |
4.0 |
2mg |
1.8mg |
-8.1% |
99.83% |
Lab F |
| 17 Nov 2025 |
IGF-1 LR3 |
5.1 |
10mg |
10.5mg |
+4.7% |
95.43% |
Lab G |
| 17 Nov 2025 |
Selank |
7.3 |
20mg |
17.4mg |
-12.9% |
95.19% |
Lab D |
| 14 Nov 2025 |
IGF-1 LR3 |
4.0 |
15mg |
13.8mg |
-8.0% |
99.98% |
Lab F |
| 14 Nov 2025 |
Sleep Blend (GABA 100mg+Histidine 100mg+L-Theanine 50mg+Taurine 100mg+Melatonin 2mg) |
4.0 |
100mg/ml |
96.3mg/ml |
-3.7% |
98.92% |
Lab D |
| 4 Nov 2025 |
Boldenone Cypionate |
4.0 |
200mg/ml |
187.4mg/ml |
-6.3% |
95.72% |
Lab C |
| 17 Oct 2025 |
RAD-140 (Testolone) Raw |
4.0 |
500g |
526.1g |
+5.2% |
97.86% |
Lab C |
| 9 Oct 2025 |
Stanozolol (Winstrol) Raw |
4.8 |
100g |
119.8g |
+19.8% |
98.63% |
Lab C |
| 9 Oct 2025 |
Tren Hex |
5.8 |
250mg/ml |
217.5mg/ml |
-13.0% |
97.45% |
Lab C |
| 3 Oct 2025 |
P-2-P (phenyl-2-propanone / BMK) CAS 103-79-7 |
4.4 |
10g |
11.5g |
+14.8% |
95.55% |
Lab A |
| 20 Mar 2025 |
Melanotan II |
|
3.7 |
10mg |
3.29mg |
-67.1% |
White Label / Silver Crimp / Yellow Cap |
| 20 Mar 2025 |
CJC-1295 |
DAC |
2.0 |
5mg |
⚠️ Sample does not contain CJC-1295 (DAC)? |
009 |
Medu Laboratories |
| 20 Mar 2025 |
Melanotan II |
|
3.6 |
10mg |
3.62mg |
-63.8% |
White Label / Silver Crimp / Yellow Cap |
| 20 Mar 2025 |
Semaglutide |
|
6.0 |
5mg |
2.79mg |
-44.2% |
White Label / Silver Crimp / White Cap |
| 20 Mar 2025 |
CJC-1295 |
DAC |
2.0 |
5mg |
⚠️ Sample does not contain CJC-1295 (DAC)? |
009 |
Medu Laboratories |
| 20 Mar 2025 |
BPC-157 |
|
2.0 |
5mg |
⚠️ Sample does not contain BPC-157 ? |
014 |
Medu Laboratories |
| 20 Mar 2025 |
Ipamorelin |
|
2.3? |
5mg |
1.32mg |
-73.6% |
White Label / Silver Crimp / Pink Cap |